Prevalence of Metabolic Syndrome in Patients ≤45 Years of Age With Acute Myocardial Infarction Having Percutaneous Coronary Intervention

The prevalence of metabolic syndrome (MS) was determined in patients aged ≤45 years who presented with acute myocardial infarction and underwent primary percutaneous coronary intervention. Two hundred twenty-three consecutive patients aged 18 to 45 years who underwent cardiac catheterization for acu...

Full description

Saved in:

Bibliographic Details
Published in:	The American journal of cardiology 2007-10, Vol.100 (7), p.1052-1055
Main Authors:	Chung, Eugene H., MD, Curran, Patrick J., MD, Sivasankaran, Satish, MD, Chauhan, Manish S., MD, Gossman, David E., MD, Pyne, Christopher T., MD, Piemonte, Thomas C., MD, Waters, James, MD, Bilazarian, Seth, MD, Riskala, Nabila, MPH, Shoraki, Azadeh, BS, Nesto, Richard W., MD
Format:	Article
Language:	eng
Subjects:	Adolescent Adult Age Factors Angioplasty Angioplasty, Balloon, Coronary Biological and medical sciences Cardiology. Vascular system Cardiovascular Cardiovascular disease Catheters Coronary heart disease Diseases of the cardiovascular system Female Heart Humans Male Medical sciences Metabolic diseases Metabolic syndrome Metabolic Syndrome - complications Metabolic Syndrome - epidemiology Middle Aged Miscellaneous Myocardial Infarction - etiology Myocardial Infarction - therapy Myocarditis. Cardiomyopathies Other metabolic disorders Prevalence Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects) Sex Factors Smoking - adverse effects United States - epidemiology
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	The prevalence of metabolic syndrome (MS) was determined in patients aged ≤45 years who presented with acute myocardial infarction and underwent primary percutaneous coronary intervention. Two hundred twenty-three consecutive patients aged 18 to 45 years who underwent cardiac catheterization for acute myocardial infarction from June 2001 to December 2004 were reviewed. MS was diagnosed by National Cholesterol Education Program Adult Treatment Panel III guidelines (modified by substituting body mass index ≥28.8 kg/m2 for waist circumference). One hundred sixty-one patients met all 5 criteria for MS available for evaluation. Seventy-six of these patients (47%) met ≥3 of the 5 criteria for MS. Sixteen patients with MS (21%) and 5 patients without MS (6%) had diabetes mellitus. The prevalence of each criterion was significantly higher (p
ISSN:	0002-9149 1879-1913